Sale of Genentech Shares Protested

Shareholders’ attorneys claimed in a lawsuit that Swiss drugmaker Roche is abusing its power as the majority owner of biotech giant Genentech with a bid to buy the remaining shares at an allegedly low price unfair to minority investors.
SFGate